FDA extends PDUFA for Theratechnologies' ibalizumab to treat HIV

Theratechnologies Inc. (TSX:TH) and TaiMed Biologics Inc. (TPEx:4147) said FDA extended by 3 months the PDUFA date for

Read the full 183 word article

User Sign In